SCHEMBL13457679

SCHEMBL13457679

CNC(=O)c1c(-c2ccc(C)cc2)oc2ccc(-c3cccc(C(=O)N[C@H]4CCC[C@H]4C(N)=O)c3)cc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.41
CYP2C8 P10632 5/20 0.41
KCNH2 Q12809 2/20 0.40
NR1I2 O75469 1/20 0.39
ANO1 Q5XXA6 2/20 0.38
RAB9A P51151 2/20 0.35
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35
HPGD P15428 2/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
PTGS2 P35354 1/20 0.35
FAAH O00519 1/20 0.35
LMNA P02545 1/20 0.34
TSHR P16473 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10241973 0.93 CYP3A4 (0.47) CYP3A4CYP2C8KCNH2NR1I2FAAH
SCHEMBL17340641 0.93 CYP3A4 (0.47) CYP3A4CYP2C8KCNH2NR1I2FAAH
SCHEMBL10240173 0.79 CYP3A4 (0.51) CYP3A4CYP2C8KCNH2NR1I2RAB9A
SCHEMBL10242040 0.77 CYP3A4 (0.51) CYP3A4CYP2C8KCNH2NR1I2RAB9A
SCHEMBL10240293 0.77 CYP3A4 (0.53) CYP3A4CYP2C8KCNH2NR1I2FAAH
SCHEMBL10280745 0.77 CYP3A4 (0.45) CYP3A4CYP2C8KCNH2NR1I2FAAH
SCHEMBL1918586 0.77 CYP3A4 (0.45) CYP3A4CYP2C8KCNH2NR1I2FAAH
SCHEMBL1918585 0.77 CYP3A4 (0.45) CYP3A4CYP2C8KCNH2NR1I2FAAH
SCHEMBL10240158 0.77 CYP3A4 (0.51) CYP3A4CYP2C8KCNH2NR1I2RAB9A
SCHEMBL10240161 0.77 CYP3A4 (0.51) CYP3A4CYP2C8KCNH2NR1I2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010030592-A1 COMPOUNDS FOR THE TREATMENT OF HEPATITIS C BRISTOL-MYERS SQUIBB COMPANY (US) 2010-03-18 WO disclosed